|
|
NEK6与肿瘤关系的研究进展
|
Abstract:
人类NIMA相关激酶(NIMA-related kinases, NEK)是一组在人类细胞中表达的与NIMA同源的蛋白激酶，它们通常在细胞周期的调控中扮演着重要的角色。目前在人类基因组中已经鉴定出NEK1到NEK11等多个成员，其中人类NIMA相关激酶6 (Human NIMA-related kinases 6, NEK6)正是其中的重要成员之一。NEK6在动物细胞中普遍表达，其主要位于细胞核内，是一种多功能细胞调控因子，它不但可以影响细胞周期的进程和细胞的稳定性，同时还可以作为信号转导因子参与调控多种信号转导通路。随着分子生物学技术的不断发展以及医疗的进步，NEK6与各种肿瘤发生发展的关系也逐步引起了公众的广泛关注。截至目前的研究表明：多种恶性肿瘤的生物学行为显著受到NEK6异常表达的影响，本文将归纳并总结NEK6参与调控乳腺癌、胃癌、肝癌及肾细胞癌等恶性肿瘤的机制并进行综述。
Human NIMA-related kinases (NEK) are a group of protein kinases homologous to NIMA expressed in human cells, which generally play an important role in the regulation of the cell cycle. Several members of NEK1 to NEK11 have been identified in the human genome, among which human NIMA-related kinases 6 (NEK6) is one of the important members. NEK6 is widely expressed in animal cells, mainly located in the nucleus, and is a multifunctional cell regulator, which can not only affect the progress of the cell cycle and the stability of cells, but also participate in the regulation of a variety of signal transduction pathways as a signal transduction factor. With the continuous development of molecular biology technology and medical advancement, the relationship between NEK6 and the development of various tumorigenesis has gradually attracted extensive public attention. This article will summarize the mechanism of NEK6 in the regulation of breast cancer, gastric cancer, liver cancer and renal cell carcinoma.
| [1] | Huang, M., Gao, X., Qiu, J.F., Gou, M., et al. (2013) Preparation and Characterization of Monomethoxy Poly(ethylene Glycol)-Poly(ε-Caprolactone) Micelles for the Solubilization and in Vivo Delivery of Luteolin. International Journal of Nanomedicine, 8, 3061-3069. https://doi.org/10.2147/ijn.s45062 |
| [2] | Xu, A., Wang, Q. and Lin, T. (2020) Low-Frequency Magnetic Fields (LF-MFs) Inhibit Proliferation by Triggering Apoptosis and Altering Cell Cycle Distribution in Breast Cancer Cells. International Journal of Molecular Sciences, 21, Article 2952. https://doi.org/10.3390/ijms21082952 |
| [3] | Chen, G., Xu, Y., Shen, S. and Zhang, J. (2018) Phenotype and Target-Based Chemical Biology Investigations in Cancers. National Science Review, 6, 1111-1127. https://doi.org/10.1093/nsr/nwy124 |
| [4] | Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R.L., Soerjomataram, I., et al. (2024) Global Cancer Statistics 2022: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 74, 229-263. https://doi.org/10.3322/caac.21834 |
| [5] | Kaur, R., Bhardwaj, A. and Gupta, S. (2023) Cancer Treatment Therapies: Traditional to Modern Approaches to Combat Cancers. Molecular Biology Reports, 50, 9663-9676. https://doi.org/10.1007/s11033-023-08809-3 |
| [6] | Helisz, P., Dziubanek, G., Krupa-Kotara, K., Gwioździk, W., Grajek, M. and Głogowska-Ligus, J. (2022) Colorectal Cancer and the Role of the Gut Microbiota—Do Medical Students Know More than Other Young People?—Cross-Sectional Study. Nutrients, 14, Article 4185. https://doi.org/10.3390/nu14194185 |
| [7] | Fu, B., Xue, W., Zhang, H., Zhang, R., Feldman, K., Zhao, Q., et al. (2020) Microrna-325-3p Facilitates Immune Escape of Mycobacterium Tuberculosis through Targeting LNX1 via NEK6 Accumulation to Promote Anti-Apoptotic STAT3 Signaling. mBio, 11, e00557-20. https://doi.org/10.1128/mbio.00557-20 |
| [8] | Hashimoto, Y., Akita, H., Hibino, M., Kohri, K. and Nakanishi, M. (2002) Identification and Characterization of Nek6 Protein Kinase, a Potential Human Homolog of NIMA Histone H3 Kinase. Biochemical and Biophysical Research Communications, 293, 753-758. https://doi.org/10.1016/s0006-291x(02)00297-8 |
| [9] | O’Regan, L. and Fry, A.M. (2009) The Nek6 and Nek7 Protein Kinases Are Required for Robust Mitotic Spindle Formation and Cytokinesis. Molecular and Cellular Biology, 29, 3975-3990. https://doi.org/10.1128/mcb.01867-08 |
| [10] | Yin, M., Shao, L., Voehringer, D., Smeal, T. and Jallal, B. (2003) The Serine/Threonine Kinase NEK6 Is Required for Cell Cycle Progression through Mitosis. Journal of Biological Chemistry, 278, 52454-52460. https://doi.org/10.1074/jbc.m308080200 |
| [11] | Lee, M., Kim, H., Kim, M., Jee, H.J., Kim, A.J., Bae, Y., et al. (2008) NEK6 Is Involved in G2/M Phase Cell Cycle Arrest through DNA Damage-Induced Phosphorylation. Cell Cycle, 7, 2705-2709. https://doi.org/10.4161/cc.7.17.6551 |
| [12] | Panchal, N.K., Mohanty, S. and Prince, S.E. (2022) Nima-Related Kinase-6 (NEK6) as an Executable Target in Cancer. Clinical and Translational Oncology, 25, 66-77. https://doi.org/10.1007/s12094-022-02926-4 |
| [13] | Qin, Y., Li, C., Shi, X. and Wang, W. (2022) MLP-Based Regression Prediction Model for Compound Bioactivity. Frontiers in Bioengineering and Biotechnology, 10, Article 946329. https://doi.org/10.3389/fbioe.2022.946329 |
| [14] | 周夏婕, 雷水芳, 黎立喜, 等. 中国女性外周血EMR3基因甲基化水平与乳腺癌的相关性[J]. 南方医科大学学报, 2021, 41(10): 1456-1463. |
| [15] | Katsura, C., Ogunmwonyi, I., Kankam, H.K. and Saha, S. (2022) Breast Cancer: Presentation, Investigation and Management. British Journal of Hospital Medicine, 83, 1-7. https://doi.org/10.12968/hmed.2021.0459 |
| [16] | Yang, Z., Liao, B., Yang, S., Su, T., Zhang, J. and Wang, W. (2022) Predictive Role of NEK6 in Prognosis and Immune Infiltration in Head and Neck Squamous Cell Carcinoma. Frontiers in Endocrinology, 13, Article 943686. https://doi.org/10.3389/fendo.2022.943686 |
| [17] | 付琳琳, 李静, 顾元忻, 等. Nek6在不同乳腺癌分子分型中的表达及其与临床病理特征的关系及意义[J]. 浙江实用医学, 2021, 26(5): 409-411. |
| [18] | Gao, W., Niu, L., Chen, W., Zhang, Y. and Huang, W. (2022) Integrative Analysis of the Expression Levels and Prognostic Values for NEK Family Members in Breast Cancer. Frontiers in Genetics, 13, Article 798170. https://doi.org/10.3389/fgene.2022.798170 |
| [19] | Adib, R., Montgomery, J.M., Atherton, J., O’Regan, L., Richards, M.W., Straatman, K.R., et al. (2019) Mitotic Phosphorylation by NEK6 and NEK7 Reduces the Microtubule Affinity of EML4 to Promote Chromosome Congression. Science Signaling, 12, eaaw2939. https://doi.org/10.1126/scisignal.aaw2939 |
| [20] | He, Z., Ni, X., Xia, L. and Shao, Z. (2018) Overexpression of Nima-Related Kinase 6 (NEK6) Contributes to Malignant Growth and Dismal Prognosis in Human Breast Cancer. Pathology—Research and Practice, 214, 1648-1654. https://doi.org/10.1016/j.prp.2018.07.030 |
| [21] | Li, X., Ramadori, P., Pfister, D., Seehawer, M., Zender, L. and Heikenwalder, M. (2021) The Immunological and Metabolic Landscape in Primary and Metastatic Liver Cancer. Nature Reviews Cancer, 21, 541-557. https://doi.org/10.1038/s41568-021-00383-9 |
| [22] | Naidoo, S., Daniels, A., Habib, S. and Singh, M. (2022) Poly-l-Lysine-Lactobionic Acid-Capped Selenium Nanoparticles for Liver-Targeted Gene Delivery. International Journal of Molecular Sciences, 23, Article 1492. https://doi.org/10.3390/ijms23031492 |
| [23] | Wang, Y., Zhang, Y., Mi, J., Jiang, C., Wang, Q., Li, X., et al. (2022) ANKFN1 Plays Both Protumorigenic and Metastatic Roles in Hepatocellular Carcinoma. Oncogene, 41, 3680-3693. https://doi.org/10.1038/s41388-022-02380-0 |
| [24] | Shao, S., Hu, Q., Wang, M., Zhao, X., Wu, W., Huang, J., et al. (2019) Impact of National Human Development Index on Liver Cancer Outcomes: Transition from 2008 to 2018. World Journal of Gastroenterology, 25, 4749-4763. https://doi.org/10.3748/wjg.v25.i32.4749 |
| [25] | 沈健. NIMA相关激酶6在肝细胞肝癌中的表达及其临床意义[J]. 中国医药指南, 2013, 11(35): 413-414. |
| [26] | 张标, 张海, 李相成. NIMA相关蛋白激酶6在肝癌组织的表达及意义[J]. 江苏医药, 2014, 40(24): 2967-2969, 2956. |
| [27] | Zuo, J., Ma, H., Cai, H., Wu, Y., Jiang, W. and Yu, L. (2015) An Inhibitory Role of NEK6 in TGFβ/Smad Signaling Pathway. BMB Reports, 48, 473-478. https://doi.org/10.5483/bmbrep.2015.48.8.225 |
| [28] | Xie, B., Hao, Q., Zhou, X. and Chen, D. (2022) Inactivation of Tumor Suppressor TAp63 by Hepatitis B Virus X Protein in Hepatocellular Carcinoma. Chinese Medical Journal, 135, 1728-1733. https://doi.org/10.1097/cm9.0000000000002283 |
| [29] | Wang, N., Zhu, M., Wang, X., Tan, H., Tsao, S. and Feng, Y. (2014) Berberine-induced Tumor Suppressor P53 Up-Regulation Gets Involved in the Regulatory Network of MIR-23a in Hepatocellular Carcinoma. Biochimica et Biophysica Acta (BBA)—Gene Regulatory Mechanisms, 1839, 849-857. https://doi.org/10.1016/j.bbagrm.2014.05.027 |
| [30] | Jin, J., Wang, S., Cui, J., Li, L., Li, J., Liu, F., et al. (2019) Hypo-Phosphorylated CD147 Promotes Migration and Invasion of Hepatocellular Carcinoma Cells and Predicts a Poor Prognosis. Cellular Oncology, 42, 537-554. https://doi.org/10.1007/s13402-019-00444-0 |
| [31] | Chen, J., Li, L., Zhang, Y., Yang, H., Wei, Y., Zhang, L., et al. (2006) Interaction of Pin1 with NEK6 and Characterization of Their Expression Correlation in Chinese Hepatocellular Carcinoma Patients. Biochemical and Biophysical Research Communications, 341, 1059-1065. https://doi.org/10.1016/j.bbrc.2005.12.228 |
| [32] | Wang, Z., Chen, Y., Li, X., Zhang, Y., Zhao, X., Zhou, H., et al. (2022) Tegaserod Maleate Suppresses the Growth of Gastric Cancer in Vivo and in Vitro by Targeting MEK1/2. Cancers, 14, Article 3592. https://doi.org/10.3390/cancers14153592 |
| [33] | López, M.J., Carbajal, J., Alfaro, A.L., Saravia, L.G., Zanabria, D., Araujo, J.M., et al. (2023) Characteristics of Gastric Cancer around the World. Critical Reviews in Oncology/Hematology, 181, Article ID: 103841. https://doi.org/10.1016/j.critrevonc.2022.103841 |
| [34] | Zhou, Y., Sun, X., Zhou, L. and Zhang, X. (2020) Ph-sensitive and Long-Circulation Nanoparticles for Near-Infrared Fluorescence Imaging-Monitored and Chemo-Photothermal Synergistic Treatment against Gastric Cancer. Frontiers in Pharmacology, 11, Article 610883. https://doi.org/10.3389/fphar.2020.610883 |
| [35] | 徐继, 牟一平, 叶再元. NEK-6在胃癌中的表达及其与浸润转移的关系[C]//2015中国外科周暨第25届国际外科、胃肠科及肿瘤科医师协会会议论文集. 2015: 328-328. |
| [36] | Takeno, A., Takemasa, I., Doki, Y., Yamasaki, M., Miyata, H., Takiguchi, S., et al. (2008) Integrative Approach for Differentially Overexpressed Genes in Gastric Cancer by Combining Large-Scale Gene Expression Profiling and Network Analysis. British Journal of Cancer, 99, 1307-1315. https://doi.org/10.1038/sj.bjc.6604682 |
| [37] | Nguyen, K., Boehling, J., Tran, M.N., Cheng, T., Rivera, A., Collins-Burow, B.M., et al. (2023) NEK Family Review and Correlations with Patient Survival Outcomes in Various Cancer Types. Cancers, 15, Article 2067. https://doi.org/10.3390/cancers15072067 |
| [38] | Orenay-Boyacioglu, S., Kasap, E., Gerceker, E., Yuceyar, H., Demirci, U., Bilgic, F., et al. (2018) Expression Profiles of Histone Modification Genes in Gastric Cancer Progression. Molecular Biology Reports, 45, 2275-2282. https://doi.org/10.1007/s11033-018-4389-z |
| [39] | Johnson, M., Nowlan, S., Sahin, G., Barnett, D.A., Joy, A.P., Touaibia, M., et al. (2022) Decrease of Intracellular Glutamine by STF-62247 Results in the Accumulation of Lipid Droplets in Von Hippel-Lindau Deficient Cells. Frontiers in Oncology, 12, Article 841054. https://doi.org/10.3389/fonc.2022.841054 |
| [40] | Wang, Q., Tang, H., Luo, X., Chen, J., Zhang, X., Li, X., et al. (2022) Immune-Associated Gene Signatures Serve as a Promising Biomarker of Immunotherapeutic Prognosis for Renal Clear Cell Carcinoma. Frontiers in Immunology, 13, Article 890150. https://doi.org/10.3389/fimmu.2022.890150 |
| [41] | Li, S., Jia, Z., Yang, J. and Ning, X. (2022) Telomere-Related Gene Risk Model for Prognosis and Drug Treatment Efficiency Prediction in Kidney Cancer. Frontiers in Immunology, 13, Article 975057. https://doi.org/10.3389/fimmu.2022.975057 |
| [42] | Zhu, Y., Lin, J., Li, Y. and Luo, Z. (2024) Prognostic Value and Immune Infiltration of the NEK Family in Clear Cell Renal Cell Carcinoma. Medicine, 103, e38961. https://doi.org/10.1097/md.0000000000038961 |
| [43] | Wang, X.J., Li, S., Fang, J., Yan, Z.J. and Luo, G.C. (2022) LncRNA FAM13A-AS1 Promotes Renal Carcinoma Tumorigenesis through Sponging miR-141-3p to Upregulate NEK6 Expression. Frontiers in Molecular Biosciences, 9, Article 738711. https://doi.org/10.3389/fmolb.2022.738711 |
| [44] | 王晓燕, 冯景见, 何英霞, 等. miR-219-5p对人肾癌细胞增殖和迁移、侵袭的影响及其作用机制[J]. 南昌大学学报(医学版), 2022, 62(1): 24-31, 47. |
